Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of Deferred Tax Assets (Details)

v3.26.1
Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 6,629 $ 4,270
Research and development carryforwards 1,091 942
Capitalized research and development 1,916 2,616
Stock-based compensation expense 25 10
Intangible assets 4 4
Other, net 71 173
Gross deferred tax assets 9,736 8,015
Less: valuation allowance (9,736) (8,015)
Total deferred tax assets